TY - JOUR
T1 - Polyneuropathy Quality Measurement Set
T2 - Quality Improvement in Neurology
AU - Callaghan, Brian C.
AU - Armon, Carmel
AU - Bril, Vera
AU - Colbert, Lindsay
AU - David, William S.
AU - Del Toro, David R.
AU - Fink, Kenneth
AU - Jones, Lyell K.
AU - Kleemeier, Robert
AU - MacGregor, Leslie C.
AU - Bennett, Amy
AU - Shenoy, Anant
N1 - Publisher Copyright:
Copyright © 2021 American Academy of Neurology.
PY - 2022/1/4
Y1 - 2022/1/4
N2 - Peripheral neuropathy affects ∼5% of the population and diabetes is the most common cause.1 Diabetic neuropathy often leads to pain, but clinicians do not always address neuropathic pain with their patients.1,2 Given the effect of painful diabetic neuropathy (PDN) on patients' quality of life, appropriate treatment of this prevalent condition is essential.1 To increase the delivery of effective management for patients with PDN, the American Academy of Neurology Institute (AANI) published a guideline on the treatment of PDN in 2011, and recently updated this guideline.1
AB - Peripheral neuropathy affects ∼5% of the population and diabetes is the most common cause.1 Diabetic neuropathy often leads to pain, but clinicians do not always address neuropathic pain with their patients.1,2 Given the effect of painful diabetic neuropathy (PDN) on patients' quality of life, appropriate treatment of this prevalent condition is essential.1 To increase the delivery of effective management for patients with PDN, the American Academy of Neurology Institute (AANI) published a guideline on the treatment of PDN in 2011, and recently updated this guideline.1
UR - http://www.scopus.com/inward/record.url?scp=85122324096&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000013037
DO - 10.1212/WNL.0000000000013037
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34965986
AN - SCOPUS:85122324096
SN - 0028-3878
VL - 98
SP - 22
EP - 30
JO - Neurology
JF - Neurology
IS - 1
ER -
